Baird Financial Group, Inc. Astrazeneca PLC Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Baird Financial Group, Inc. holds 247,666 shares of AZN stock, worth $18.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

247,666

Previous 240,951 2.79%

Holding current value

$18.6 Million

Previous $16.3 Million 18.32%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $448,629 - $542,773	6,715 Added 2.79%	247,666 $19.3 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $1.48 Million - $1.69 Million	24,228 Added 11.18%	240,951 $16.3 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $822,394 - $920,592	-13,288 Reduced 5.78%	216,723 $14.6 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $184,303 - $203,771	2,842 Added 1.25%	230,011 $15.6 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $1.28 Million - $1.39 Million	18,284 Added 8.75%	227,169 $16.3 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $8.75 Million - $9.93 Million	138,621 Added 197.29%	208,885 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $120,143 - $307,609	2,266 Added 3.25%	71,967 $3.95 Million
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $125,571 - $150,745	-2,119 Reduced 2.95%	69,701 $4.61 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $40,062 - $48,259	719 Added 1.01%	71,820 $4.77 Million
Q4 2021 Feb 09, 2022	SELL	$54.02 - $63.83 $69,739 - $82,404	-1,291 Reduced 1.78%	71,101 $4.14 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $337,527 - $369,299	6,075 Added 9.16%	72,392 $4.35 Million
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $48,807 - $60,661	-1,008 Reduced 1.5%	66,317 $3.97 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $2.28 Million - $2.63 Million	-48,322 Reduced 41.78%	67,325 $3.35 Million
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $3.14 Million - $3.75 Million	-64,648 Reduced 35.86%	115,647 $5.78 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $1.85 Million - $2.13 Million	34,838 Added 23.95%	180,295 $9.88 Million
Q2 2020 Oct 22, 2020	SELL	$43.1 - $55.31 $640,466 - $821,906	-14,860 Reduced 9.27%	145,457 $7.69 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $2.94 Million - $3.78 Million	68,262 Added 74.15%	160,317 $8.02 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $2.71 Million - $3.69 Million	-71,829 Reduced 43.83%	92,055 $4.11 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $247,754 - $294,434	5,835 Added 3.69%	163,884 $8.17 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $62,827 - $71,206	1,566 Added 1.0%	158,049 $7.05 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $3.89 Million - $4.35 Million	104,455 Added 200.77%	156,483 $6.46 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $22,358 - $27,102	-630 Reduced 1.2%	52,028 $2.1 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $13,011 - $14,645	353 Added 0.67%	52,658 $2 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $161,773 - $184,856	-4,654 Reduced 8.17%	52,305 $2.07 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $210,478 - $225,708	6,092 Added 11.98%	56,959 $2 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $74,479 - $82,747	-2,259 Reduced 4.25%	50,867 $1.78 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $12,675 - $13,738	-395 Reduced 0.74%	53,126 $1.84 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $39,762 - $46,682	-1,373 Reduced 2.5%	53,521 $1.81 Million
Q2 2017 Aug 14, 2017	BUY	N/A	54,894	54,894 $1.87 Million

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Astrazeneca PLC Transaction History